Skip to main content
Top

Current HIV/AIDS Reports

Issue 1/2014

Content (9 Articles)

HIV Pathogenesis and Treatment (AL Landay, Section Editor)

Are Infants Unique in Their Ability to be “Functionally Cured” of HIV-1?

Nicole H. Tobin, Grace M. Aldrovandi

Open Access HIV Pathogenesis and Treatment (AL Landay, Section Editor)

Practical Considerations in Gene Therapy for HIV Cure

Rodica Stan, John A. Zaia

HIV Pathogenesis and Treatment (AL Landay, Section Editor)

Inflammatory Co-morbidities in HIV+ Individuals: Learning Lessons from Healthy Ageing

Anna C. Hearps, Genevieve E. Martin, Reena Rajasuriar, Suzanne M. Crowe

HIV Pathogenesis and Treatment (AL Landay, Section Editor)

Metabolic Consequences of HIV: Pathogenic Insights

Amanda L. Willig, E. Turner Overton

The Science of Prevention (SC Kalichman, Section Editor)

People Who Inject Drugs in Intimate Relationships: It Takes Two to Combat HIV

Nabila El-Bassel, Stacey A. Shaw, Anindita Dasgupta, Steffanie A. Strathdee

The Science of Prevention (SC Kalichman, Section Editor)

The Paradigm of Universal Access to HIV-Treatment and Human Rights Violation: How Do We Treat HIV-Positive People Who Use Drugs?

Monica Malta, Michelle Ralil da Costa, Francisco Inácio Bastos

The Science of Prevention (SC Kalichman, Section Editor)

Antiretroviral Adherence Interventions in Southern Africa: Implications for Using HIV Treatments for Prevention

Sarah Dewing, Cathy Mathews, Geoffrey Fatti, Ashraf Grimwood, Andrew Boulle

The Science of Prevention (SC Kalichman, Section Editor)

HIV Prevention Interventions for Young Male Commercial Sex Workers

R. Ballester-Arnal, M. D. Gil-Llario, P. Salmeron-Sánchez, C. Giménez-García

The Science of Prevention (SC Kalichman, Section Editor)

Social Networks, Sexual Networks and HIV Risk in Men Who Have Sex with Men

Yuri A. Amirkhanian

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine